603669 灵康药业
2025/03 - 三个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)-2.449-15.377-14.668-15.1044.485
总资产报酬率 ROA (%)-1.498-9.081-8.707-8.9642.520
投入资产回报率 ROIC (%)-1.770-10.029-9.094-9.2602.622

边际利润分析
销售毛利率 (%)28.02846.88146.67267.80979.376
营业利润率 (%)-35.610-33.906-75.690-65.2269.608
息税前利润/营业总收入 (%)-27.399-33.207-76.447-65.67010.385
净利润/营业总收入 (%)-37.152-34.431-76.967-67.7118.902

收益指标分析
经营活动净收益/利润总额(%)68.53267.780103.96389.06648.031
价值变动净收益/利润总额(%)18.6135.3399.6284.30023.916
营业外收支净额/利润总额(%)4.745-0.8141.3080.069-0.920

偿债能力分析
流动比率 (X)2.7472.6753.6263.7432.756
速动比率 (X)2.6352.5483.3933.5812.676
资产负债率 (%)39.00238.68142.69038.84941.980
带息债务/全部投入资本 (%)27.40926.49839.19036.01039.555
股东权益/带息债务 (%)262.019274.441153.346176.783150.667
股东权益/负债合计 (%)156.395158.526134.249157.405138.208
利息保障倍数 (X)-2.744-78.049-310.910164.74512.006

营运能力分析
应收账款周转天数 (天)455.872145.938143.506134.24571.707
存货周转天数 (天)63.84675.527181.612194.865142.329